Streetbeat News

Earnings

NVGS

Navigator Holdings (NYSE:NVGS) reported Q4 earnings with an EPS of $0.32, beating estimates by 7%, and revenue increased by $18.35 million year-over-year. Despite beating earnings this quarter, a miss in the previous quarter led to a 1% drop in share price the next day. The company has shown fluctuating performance in past quarters.

Portfolio Pulse from Benzinga Insights

March 13, 2024 | 8:45 pm

PFIE

Profire Energy (NASDAQ:PFIE) reported Q4 earnings, beating estimates with an EPS of $0.07 against an expected $0.04, a 75% beat. Revenue increased by $400 thousand year-over-year. Despite missing EPS estimates last quarter, PFIE's share price increased by 3% the following day. The company has shown consistent revenue growth over the past four quarters.

Portfolio Pulse from Benzinga Insights

March 13, 2024 | 8:45 pm

PFIE

Profire Energy (NASDAQ:PFIE) reported Q4 2023 earnings of $0.07 per share, surpassing the $0.03 estimate, but missed sales estimates with $14.400M against the expected $14.615M. This represents a 2.86% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 8:42 pm

NVGS

Navigator Holdings (NYSE:NVGS) reported Q4 2023 adjusted EPS of $0.32, surpassing the $0.30 estimate, with sales of $141.632M exceeding the $130.762M forecast. This represents a 14.88% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 8:40 pm

VRM

Vroom, Inc. (NASDAQ:VRM) reported Q4 losses of $80.51 per share with sales of $235.92 million, surpassing analyst estimates. The company is finalizing its e-commerce wind down by Q1 2024 end, focusing on maximizing stakeholder value through United Auto Credit and CarStory. Post-announcement, VRM shares surged over 53.8% but fell 11.2% after-hours.

Portfolio Pulse from Erica Kollmann

March 13, 2024 | 8:40 pm

ANIK

Anika Therapeutics (NASDAQ:ANIK) reported Q4 earnings with an EPS of $0.05, surpassing the estimated -$0.26, marking a 119.0% beat. Revenue increased by $3.35 million year-over-year. The company has a history of beating EPS estimates, which previously led to an 11.0% share price increase the following day.

Portfolio Pulse from Benzinga Insights

March 13, 2024 | 8:40 pm

PTMN

Portman Ridge Finance (NASDAQ:PTMN) reported Q4 earnings with an EPS of $1.19, beating estimates by 51.0% against an expected $0.79. However, revenue decreased by $800 thousand compared to the same period last year. In the previous quarter, PTMN missed EPS estimates by $0.03, leading to a 2.0% drop in share price the following day. The company's earnings performance over the past four quarters shows fluctuating EPS and revenue figures.

Portfolio Pulse from Benzinga Insights

March 13, 2024 | 8:40 pm

LEN

Lennar Corporation (NYSE:LEN) reported Q1 earnings with an EPS of $2.57, beating estimates by 17.0% and showing a revenue increase of $823.00 million from the previous year. Despite past earnings beats, such as last quarter's $0.58 EPS beat, LEN's share price dropped by 4.0% the following day. The company has consistently outperformed EPS and revenue estimates over the past four quarters.

Portfolio Pulse from Benzinga Insights

March 13, 2024 | 8:40 pm

PTMN

Portman Ridge Finance (PTMN) reported Q4 2023 earnings of $1.19 per share, surpassing the $0.79 estimate by 50.63%. However, their sales of $17.800M fell short of the $19.043M estimate by 6.53%, marking a 4.30% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 8:38 pm

ANIK

Anika Therapeutics (NASDAQ:ANIK) reported Q4 2023 adjusted EPS of $0.05, surpassing the $(0.26) estimate, and sales of $42.971M, beating the $41.405M estimate. This represents a significant improvement over the previous year.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 8:36 pm